These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. Orenes-Piñero E; Hernández-Romero D; Jover E; de la Morena G; Valdés M; Marín F Med Chem; 2011 Jul; 7(4):275-85. PubMed ID: 21568880 [TBL] [Abstract][Full Text] [Related]
5. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121 [TBL] [Abstract][Full Text] [Related]
6. The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice. Olivotto I; Girolami F; Nistri S; Rossi A; Rega L; Garbini F; Grifoni C; Cecchi F; Yacoub MH J Cardiovasc Transl Res; 2009 Dec; 2(4):349-67. PubMed ID: 20559994 [TBL] [Abstract][Full Text] [Related]
7. Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy. Becker RC; Owens AP; Sadayappan S J Thromb Thrombolysis; 2020 Feb; 49(2):177-183. PubMed ID: 31898271 [TBL] [Abstract][Full Text] [Related]
9. Myocardial capillary supply is limited in hypertrophic cardiomyopathy: a morphological analysis. Johansson B; Mörner S; Waldenström A; Stål P Int J Cardiol; 2008 May; 126(2):252-7. PubMed ID: 17532066 [TBL] [Abstract][Full Text] [Related]
10. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study. Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373 [TBL] [Abstract][Full Text] [Related]
11. [Hypertrophic cardiomyopathy: course characteristics in long-term follow-up]. Belenkov IuN; Privalova EV; Kaplunova VIu; Fomin AA Ter Arkh; 2008; 80(8):18-25. PubMed ID: 18807535 [TBL] [Abstract][Full Text] [Related]
12. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610 [TBL] [Abstract][Full Text] [Related]
13. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320 [TBL] [Abstract][Full Text] [Related]
14. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Marian AJ; Salek L; Lutucuta S Minerva Med; 2001 Dec; 92(6):435-51. PubMed ID: 11740432 [TBL] [Abstract][Full Text] [Related]
15. Pathogenetic role of myocardial fiber disarray in the progression of cardiac fibrosis in normal hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy. Tanaka M; Fujiwara H; Onodera T; Wu DJ; Matsuda M; Hamashima Y; Kawai C Jpn Circ J; 1987 Jun; 51(6):624-30. PubMed ID: 2959802 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501 [TBL] [Abstract][Full Text] [Related]
18. Pathology of end-stage remodeling in a family of cats with hypertrophic cardiomyopathy. Cesta MF; Baty CJ; Keene BW; Smoak IW; Malarkey DE Vet Pathol; 2005 Jul; 42(4):458-67. PubMed ID: 16006605 [TBL] [Abstract][Full Text] [Related]
19. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography. Timmer SA; Knaapen P Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):95-101. PubMed ID: 23152441 [TBL] [Abstract][Full Text] [Related]
20. [Asymmetric septal hypertrophy of sporadic form with abnormal thallium perfusion and myocardial enzymes]. Nagata S; Minamikawa T; Park YD; Nishimura T; Yutani C; Ohmori F; Sakakibara H; Nimura Y J Cardiogr Suppl; 1986; (9):57-65. PubMed ID: 3760618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]